Literature DB >> 6193230

Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide.

C E Taylor, P W Stashak, G Caldes, B Prescott, T E Chused, A Brooks, P J Baker.   

Abstract

The transfer of B lymphocytes from mice immunized with type III pneumococcal polysaccharide (SSS-III) results in antigen-specific suppression of the antibody response of recipients immunized with SSS-III. Such suppression shares many features associated with low-dose paralysis, a phenomenon mediated by suppressor T cells; it reaches maximal levels 3 d after the transfer of viable or irradiated immune B cells and can be eliminated by the depletion of SSS-III-binding cells from spleen cell suspensions before transfer. In a two-step cell transfer experiment, purified T lymphocytes, isolated from recipients previously given immune B cells, caused suppression upon transfer to other mice immunized with SSS-III. Also, B-cell-induced suppression could be abrogated in a competitive manner by the infusion of amplifier T lymphocytes, as was previously demonstrated in the case of low-dose paralysis. These findings suggest that B cell surface components, presumably the idiotypic determinants of cell-associated antibody specific for SSS-III, are instrumental in activating suppressor T cells involved in regulating the magnitude of the antibody response to SSS-III.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193230      PMCID: PMC2187111          DOI: 10.1084/jem.158.3.703

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

2.  Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

3.  Pneumococcal antigenic polysaccharide substances from animal tissues.

Authors:  L D FELTON; B PRESCOTT; G KAUFFMANN; B OTTINGER
Journal:  J Immunol       Date:  1955-03       Impact factor: 5.422

4.  Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide.

Authors:  P J Baker; B Prescott
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

5.  Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.

Authors:  H C Morse; B Prescott; S S Cross; P W Stashak; P J Baker
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

7.  Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.

Authors:  P H Baker; P W Stashak
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

8.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.

Authors:  P J Baker; B Prescott; P W Stashak; D F Amsbaugh
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

9.  Feedback suppression of the immune response in vivo. I. Immune B cells induce antigen-specific suppressor T cells.

Authors:  T Shimamura; K Hashimoto; S Sasaki
Journal:  Cell Immunol       Date:  1982-03-15       Impact factor: 4.868

10.  Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.

Authors:  P J Baker; D F Amsbaugh; P W Stashak; G Caldes; B Prescott
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  16 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A.

Authors:  F Esquivel; C E Taylor; P J Baker
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Genes on different chromosomes influence the antibody response to bacterial antigens.

Authors:  P J Baker; D W Bailey; M B Fauntleroy; P W Stashak; G Caldes; B Prescott
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Rapid loss of feedback suppressor T-cell activity after priming in vivo.

Authors:  A L Rothermel; C E Calkins
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

Review 5.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

6.  Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.

Authors:  P J Baker; C E Taylor; P W Stashak; M B Fauntleroy; K Hasløv; N Qureshi; K Takayama
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides.

Authors:  N Tvede; C Heilmann; L D Christensen
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

8.  T-cell modulation of the antibody response to bacterial polysaccharide antigens.

Authors:  C E Taylor; R Bright
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.

Authors:  P J Baker; T Hraba; C E Taylor; K R Myers; K Takayama; N Qureshi; P Stuetz; S Kusumoto; A Hasegawa
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.